[Tumor-suppression effect of polyactin A combined with GM-CSF, TNF-alpha and IL-4 on cord blood mononuclear cells]

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2005 Oct;30(5):553-7.
[Article in Chinese]

Abstract

Objective: To investigate the tumor-suppression effect of PA combined with GM-CSF, TNF-alpha and IL-4 on cord blood mononuclear cells (CBMC).

Methods: The mononuclear cells were isolated from human umbilical cord blood and cultured with polyacttin A (PA), GM-CSF + TNF-alpha + IL-4 (GTI), and GTI + PA (GTIP) respectively. Six days later, surface antigen expression of the cultured cells, including CD1a and CD83, which were the specialized markers of dendritic cell (DC), were analyzed by immunohistochemistry technique. The CBMC were cultured with GTI for 24 h to enhance DC, then were added apoptotic/necrotic Hela/HepG2 tumor cells, and finally PA was co-cultured. The antitumor cytotoxicity of CBMC was measured by MTT assay.

Results: After the culture, CD1a and CD83 positive cell rates of the PA group inreased significantly, reaching (19.63 +/- 3.61)%, (9.28 +/- 4.31) % respectively, much higher than that of the control, but lower than that of the GTI group. The killing rate to the tumor cells of CBMC cultured with GTIP increased remarkably, much higher than the control, GTI and PA groups. After tumor antigens were added to the CBMC of GTIP group (GTIP + Tc), the killing rate increased.

Conclusion: PA not only promotes the proliferation and maturation of cord blood derived DC, but also improves the tumor-suppression effect of CBMC cultured with GTI.

Publication types

  • English Abstract
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, CD / biosynthesis
  • Antigens, CD / genetics
  • Antigens, CD1 / biosynthesis
  • Antigens, CD1 / genetics
  • CD83 Antigen
  • Cells, Cultured
  • Fetal Blood / cytology
  • Glycopeptides / pharmacology*
  • Granulocyte-Macrophage Colony-Stimulating Factor / pharmacology*
  • HeLa Cells
  • Humans
  • Immunoglobulins / biosynthesis
  • Immunoglobulins / genetics
  • Immunotherapy
  • Interleukin-4 / pharmacology*
  • Leukocytes, Mononuclear / drug effects
  • Leukocytes, Mononuclear / immunology*
  • Liver Neoplasms / pathology
  • Liver Neoplasms / therapy
  • Membrane Glycoproteins / biosynthesis
  • Membrane Glycoproteins / genetics
  • Neoplasms / therapy*
  • Tumor Cells, Cultured
  • Tumor Necrosis Factor-alpha / pharmacology

Substances

  • Antigens, CD
  • Antigens, CD1
  • Glycopeptides
  • Immunoglobulins
  • Membrane Glycoproteins
  • Tumor Necrosis Factor-alpha
  • Interleukin-4
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • polyactin A